Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

FDA Alerts

psoriasis
FDA Alerts
Bimekizumab-bkzx Approved for Adults With Moderate to Severe Plaque Psoriasis
10/19/2023
The US Food and Drug Administration recently announced approval of bimekizumab-bkzx for the treatment of adults with moderate to severe plaque psoriasis.
The US Food and Drug Administration recently announced approval of bimekizumab-bkzx for the treatment of adults with moderate to severe plaque psoriasis.
The US Food and Drug...
10/19/2023
The Dermatologist
FDA Alerts
Nivolumab Approved as Adjuvant Treatment for Patients With Completely Resected Stage IIB or Stage IIC Melanoma
10/19/2023
The US Food and Drug Administration recently announced approval of nivolumab as an adjuvant treatment for eligible patients with stage IIB or IIC completely resected melanoma.
The US Food and Drug Administration recently announced approval of nivolumab as an adjuvant treatment for eligible patients with stage IIB or IIC completely resected melanoma.
The US Food and Drug...
10/19/2023
The Dermatologist
FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
cosmetic treatment
FDA Alerts
PLLA-SCA Approved for Correction of Fine Lines and Cheek Wrinkles
05/01/2023
The US Food and Drug Administration recently announced approval of an injectable poly-L-lactic acid, for the correction of fine lines and wrinkles in cheek areas.
The US Food and Drug Administration recently announced approval of an injectable poly-L-lactic acid, for the correction of fine lines and wrinkles in cheek areas.
The US Food and Drug...
05/01/2023
The Dermatologist
doctor with patient
FDA Alerts
New Drug Application Accepted by the Food and Drug Administration for Berdazimer Gel 10.3%
03/30/2023
The FDA recently announced its acceptance of a new drug application for Novan’s berdazimer gel 10.3% for the treatment of molluscum contagiosum.
The FDA recently announced its acceptance of a new drug application for Novan’s berdazimer gel 10.3% for the treatment of molluscum contagiosum.
The FDA recently announced its...
03/30/2023
The Dermatologist
FDA Alerts
Dupilumab First and Only Treatment Approved for Adults with Prurigo Nodularis
09/29/2022
The US Food and Drug Administration recently announced approval of dupilumab as the first and only treatment indicated for adults with prurigo nodularis.
The US Food and Drug Administration recently announced approval of dupilumab as the first and only treatment indicated for adults with prurigo nodularis.
The US Food and Drug...
09/29/2022
The Dermatologist
psoriatic rash
FDA Alerts
Deucravacitinib Approved for Adults With Moderate to Severe Plaque Psoriasis
09/12/2022
Last week, the US Food and Drug Administration announced approval of deucravacitinib as an oral treatment for adults with moderate to severe plaque psoriasis.
Last week, the US Food and Drug Administration announced approval of deucravacitinib as an oral treatment for adults with moderate to severe plaque psoriasis.
Last week, the US Food and Drug...
09/12/2022
The Dermatologist
pediatric patient hand
FDA Alerts
Ustekinumab Approved For Pediatric Patients With Active Psoriatic Arthritis
08/01/2022
Today, the US Food and Drug Administration announced approval of ustekinumab for the treatment of pediatric patients aged 6 years and older with active psoriatic arthritis.
Today, the US Food and Drug Administration announced approval of ustekinumab for the treatment of pediatric patients aged 6 years and older with active psoriatic arthritis.
Today, the US Food and Drug...
08/01/2022
The Dermatologist
FDA Alerts
Baricitinib Approved for Adult Patients With Severe Alopecia Areata
06/15/2022
The US Food and Drug Administration recently announced approval of baricitinib oral tablets to treat adult patients with severe alopecia areata.
The US Food and Drug Administration recently announced approval of baricitinib oral tablets to treat adult patients with severe alopecia areata.
The US Food and Drug...
06/15/2022
The Dermatologist
FDA Alerts
FDA Approves Risankizumab-rzaa for Adult Patients With Active Psoriatic Arthritis
01/24/2022
The IL-23 inhibitor has already been approved for the treatment of plaque psoriasis.
The IL-23 inhibitor has already been approved for the treatment of plaque psoriasis.
The IL-23 inhibitor has already...
01/24/2022
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

October 2024
Volume 32
Issue 7
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Chief Medical Editor Message
So, Is It Time for You to Consider Hiring a PA?
09/04/2008
The decision about whether or not to hire a physician assistant has become something of a hot-button issue among our readers, many of whom embrace such extenders’ much-needed help while others bemoan the loss of control and diminished...
The decision about whether or not to hire a physician assistant has become something of a hot-button issue among our readers, many of whom embrace such extenders’ much-needed help while others bemoan the loss of control and diminished...
The decision about whether or...
09/04/2008
The Dermatologist
Dr Peter Lio
Videos
Insights From Mount Sinai Winter Symposium: Holistic Approaches Treating Alopecia Areata
12/07/2023
In this feature video, Dr Peter Lio discussed holistic treatments for conditions like atopic dermatitis and alopecia areata.
In this feature video, Dr Peter Lio discussed holistic treatments for conditions like atopic dermatitis and alopecia areata.
In this feature video, Dr Peter...
12/07/2023
The Dermatologist
Trivia of the Day: Long-term Maintenance of Response in Psoriasis
Quiz
Trivia of the Day: Long-term Maintenance of Response in Psoriasis
01/28/2021
Of the patients who received a 100-mg dose of tildrakizumab and achieved PASI 100 at 52 weeks in the reSURFACE 2 trial, how many maintained this level of response at the end of the trial extension?
Of the patients who received a 100-mg dose of tildrakizumab and achieved PASI 100 at 52 weeks in the reSURFACE 2 trial, how many maintained this level of response at the end of the trial extension?
Of the patients who received a...
01/28/2021
The Dermatologist
What Is the Cause of These Annular Lesions?
Derm Dx
What Is the Cause of These Annular Lesions?
12/14/2020
A 36-year-old man with a history of chronic back pain presented for evaluation of an atypical nevus on the right leg. A complete skin examination was performed. A dark brown 2- x 2-mm macule was found on his right...
A 36-year-old man with a history of chronic back pain presented for evaluation of an atypical nevus on the right leg. A complete skin examination was performed. A dark brown 2- x 2-mm macule was found on his right...
A...
12/14/2020
The Dermatologist
Case Report
Successful Treatment of Recalcitrant Hailey-Hailey Disease
02/06/2024
In this article, we present a patient with a history of recalcitrant HHD who had clearance of her current disease flare with the topical JAK inhibitor ruxolitinib.
In this article, we present a patient with a history of recalcitrant HHD who had clearance of her current disease flare with the topical JAK inhibitor ruxolitinib.
In this article, we present a...
02/06/2024
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement